The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Buprenorphine Treatment for Probationers and Parolees
Open accessAbstract
Background: Pharmacotherapy studies involving buprenorphine have rarely been conducted with US community corrections populations. This is one of the first reports of buprenorphine treatment outcomes of adult opioid-dependent probationers and parolees. Methods: This longitudinal study examined the 3-month treatment outcomes for a sample of probation and parole clients ( N = 64) who received community-based buprenorphine treatment. Results: Approximately two thirds of the sample (67%) were still in treatment at 3 months post baseline. Furthermore, there was a significant decline in the number of self-reported heroin use days and crime days from baseline to 3 months post baseline. Although there was not a significant reduction in reincarcerations, there was no evidence that they had increased. Conclusions: Given that buprenorphine is approved by the Food and Drug Administration (FDA) as a safe, effective treatment for opioid use disorders, individuals on parole or probation should have the opportunity to benefit from it through community-based programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Methadone and buprenorphine maintenance treatments are effective for opioid dependence in prison, jail, and community reentry settings.
“Evidence-based opioid-agonist maintenance therapies for opioid dependence (methadone and buprenorphine) are effective in prison, jail, and community reentry (i.e., parole) settings2–5 but have historically been unavailable or discouraged among criminal justice clients.6–8”
From Extended-release naltrexone to prevent opioid relapse in criminal justice offenders (2016) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C. L., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,312
Wilson, J. Q., & Herrnstein, R. J. (1985) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,486
Substance Abuse: A Comprehensive Textbook
Liskow, B. I. (1998) · JAMA · doi:10.1001/jama.279.10.802-a · Cited by 712
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A New Measure of Substance Abuse Treatment Initial Studies of the Treatment Services Review
McLellan, A. T., Alterman, A. I., Cacciola, J., Metzger, D. S., & OʼBRIEN, C. P. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199202000-00007 · Cited by 421
Office of National Drug Control Policy
Sullivan, L. E., Rosen, M. S., Schulz, D. M., & Haberfeld, M. R. (2004) · Encyclopedia of Law Enforcement · doi:10.4135/9781412952415.n342 · Cited by 416
Effects of readiness for drug abuse treatment on client retention and assessment of process
George, W., Joe, D., Simpson, D., & Broome, K. M. (1998) · Addiction · doi:10.1080/09652149835008 · Cited by 379
Criminological theory: context and consequences
Lilly, J. R., Cullen, F. T., & Ball, R. A. (1990) · Choice Reviews Online · doi:10.5860/choice.27-3011 · Cited by 353
Probation and Parole in the United States, 1998
Bonczar, T. P., & Glaze, L. E. (1999) · PsycEXTRA Dataset · doi:10.1037/e522932006-001 · Cited by 286
Alford, D. P., LaBelle, C. T., Kretsch, N., Bergeron, A., Winter, M., Botticelli, M., & Samet, J. H. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.541 · Cited by 267
Friedmann, P. D., Hoskinson, R. A., Gordon, M., Schwartz, R. P., Kinlock, T. W., Knight, K. K., Flynn, P. M., Welsh, W. N., Stein, L. A. R., Sacks, S., et al. (2012) · Substance Abuse · doi:10.1080/08897077.2011.611460 · Cited by 224
Self-citationBuprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial
Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.006 · Cited by 223
Naltrexone pharmacotherapy for opioid dependent federal probationers
Cornish, J., Metzger, D. S., WOODY, G. E., Wilson, D., McLellan, A. T., Vandergrift, B., & O’Brien, C. P. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00020-2 · Cited by 213
Criminological Theory: Context and Consequences.
Degher, D., Lilly, J. R., Cullen, F. T., & Ball, R. J. (1990) · Contemporary Sociology A Journal of Reviews · doi:10.2307/2072358 · Cited by 208
Gordon, M. S., Kinlock, T. W., Schwartz, R. P., & O’Grady, K. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.002238.x · Cited by 176
Self-citationA randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release
Kinlock, T. W., Gordon, M., Schwartz, R. P., O’Grady, K. E., Fitzgerald, T. T., & Wilson, M. E. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.05.022 · Cited by 140
Self-citationAnglin, M. D., Brecht, M., & Maddahian, E. (1989) · Criminology · doi:10.1111/j.1745-9125.1989.tb01045.x · Cited by 134
A Long-Term Program of Research on Drug Use and Crime
Nurco, D. N. (1998) · Substance Use & Misuse · doi:10.3109/10826089809059323 · Cited by 89
Fiellin, D., Weiss, L., Botsko, M., Egan, J. E., Altice, F., Bazerman, L., Chaudhry, A., Cunningham, C., Gourevitch, M., Lum, P. J., et al. (2011) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182097537 · Cited by 88
Scott, C. K., & Dennis, M. L. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.03.025 · Cited by 69
Buprenorphine treatment in an urban community health center: what to expect.
Cunningham, C. O., Giovanniello, A., Sacajiu, G. M., Whitley, S. D., Mund, P. A., Beil, R., & Sohler, N. (2008) · PubMed · Cited by 61
Coviello, D. M., Cornish, J. W., Lynch, K. G., Boney, T. Y., Clark, C. A., Lee, J. D., Friedmann, P. D., Nunes, E. V., Kinlock, T. W., Gordon, M. S., et al. (2012) · Substance Abuse · doi:10.1080/08897077.2011.609438 · Cited by 58
Self-citationA Randomized Trial of Probation Case Management for Drug-Involved Women Offenders
Guydish, J. R., Chan, M., Bostrom, A., Jessup, M. A., Davis, T. B., & Marsh, C. (2008) · Crime & Delinquency · doi:10.1177/0011128708318944 · Cited by 53
A Randomized Trial of Oral Naltrexone for Treating Opioid‐Dependent Offenders
Coviello, D. M., Cornish, J. W., Lynch, K. G., Alterman, A. I., & O’Brien, C. P. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00070.x · Cited by 50
Mitchell, S. G., Gryczynski, J., Schwartz, R. P., O’Grady, K. E., Olsen, Y. K., & Jaffe, J. H. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.08.027 · Cited by 50
Self-citationPrediction of the Criminal Activity of Incarcerated Drug-Abusing Offenders
Kinlock, T. W., O’Grady, K. E., & Hanlon, T. E. (2003) · Journal of Drug Issues · doi:10.1177/002204260303300406 · Cited by 49
Self-citationBuprenorphine-Naloxone Maintenance following Release from Jail
Lee, J. D., Grossman, E., Truncali, A., Rotrosen, J., Rosenblum, A., Magura, S., & Gourevitch, M. N. (2012) · Substance Abuse · doi:10.1080/08897077.2011.620475 · Cited by 47
Center for Substance Abuse Treatment (CSAT)
Davis, M. S. (2002) · The Concise Dictionary of Crime and Justice · doi:10.4135/9781452229300.n324 · Cited by 46
Cropsey, K. L., Lane, P. S., Hale, G. J., Jackson, D. O., Clark, C. B., Ingersoll, K. S., Islam, M. A., & Stitzer, M. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.021 · Cited by 45
Legal status and long-term outcomes for addicts in the DARP followup project.
Dd, S., & Hj, F. (1988) · PubMed · Cited by 43
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program
Kinlock, T. W., Gordon, M., Schwartz, R. P., & Fitzgerald, T. T. (2010) · Journal of Offender Rehabilitation · doi:10.1080/10509670903534951 · Cited by 34
Self-citationPredictors of Drug Treatment Completion Among Parole Violators
Zanis, D. A., Coviello, D. M., Lloyd, J. J., & Nazar, B. L. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10399910 · Cited by 32
Vulnerability to Narcotic Addiction: Preliminary Findings
Nurco, D. N., Balter, M. B., & Kinlock, T. W. (1994) · Journal of Drug Issues · doi:10.1177/002204269402400206 · Cited by 32
Self-citationCompulsory supervision and methadone maintenance
Desmond, D. P., & Maddux, J. F. (1996) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(95)02024-1 · Cited by 30
Grella, C. E., Anglin, M. D., Wugalter, S. E., Rawson, R. A., & Hasson, A. L. (1994) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1994.10472270 · Cited by 30
Gordon, M., Kinlock, T. W., & Miller, P. M. (2011) · Behavioral Sciences & the Law · doi:10.1002/bsl.1015 · Cited by 28
Self-citationEffect of Incarceration History on Outcomes of Primary Care Office-based Buprenorphine/Naloxone
Wang, E. A., Moore, B. A., Sullivan, L. E., & Fiellin, D. A. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1306-0 · Cited by 25
Workgroup, F. T. C.-D. M., Friedmann, P. D., Ducharme, L. J., Welsh, W. N., Frisman, L. K., Knight, K. K., Kinlock, T. W., Mitchell, S. G., Hall, E. A., Urbine, T. F., et al. (2013) · Health & Justice · doi:10.1186/2194-7899-1-6 · Cited by 24
Self-citationKelly, S. M., O’Grady, K. E., Jaffe, J. H., Gandhi, D. H., & Schwartz, R. P. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e318284a0c1 · Cited by 20
Self-citationThe Early Emergence of Narcotic Addict Types
Nurco, D. N., Hanlon, T. E., O’Grady, K. E., & Kinlock, T. W. (1997) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999709016893 · Cited by 13
Self-citationGordon, M., Kinlock, T. W., Couvillion, K. A., Wilson, M. E., Schwartz, R. P., & O’Grady, K. E. (2013) · Journal of Offender Rehabilitation · doi:10.1080/10509674.2013.801386 · Cited by 11
Self-citation
Flagged first, then by citations
Research works printed but not linked: 8
- Schmalleger F., 2010, Criminal Justice Today: An Introductory Text for the 21st Century
- Inciardi JA., 2008, The War on Drugs IV
- Simpson DD, 1988, Compulsory Treatment of Drug Abuse: Research and Clinical Practice, 81
- Epstein DH, 2011, Substance Abuse: A Comprehensive Textbook, 161
- Kinlock TW, 2011, Lowinson & Ruiz's Substance Abuse: A Comprehensive Textbook, 881
- Cunningham C, 2008, Fam Med., 40, 500
- Mattick RP, 2008, Cochrane Database Syst Rev., CD002207
- Kinlock TW, 2006, New Topics in Substance Abuse Treatment, 73
Cited by
Sorted by citations
Extended-release naltrexone to prevent opioid relapse in criminal justice offenders
Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A., Wilson, D., McDonald, R., Rotrosen, J., Gourevitch, M. N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505409 · Cited by 315
Self-citationMitchell, S. G., Willet, J., Monico, L. B., James, A., Rudes, D. S., Viglioni, J., Schwartz, R. P., Gordon, M., & Friedmann, P. D. (2016) · Substance Abuse · doi:10.1080/08897077.2015.1129389 · Cited by 79
Self-citationA Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners
Gordon, M., Kinlock, T. W., Vocci, F. J., Fitzgerald, T. T., Memisoglu, A., & Silverman, B. L. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.07.005 · Cited by 51
Self-citationMurphy, S. M., Polsky, D. E., Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Bonnie, R. J., Gordon, M., Chen, D. T., Boney, T. Y., et al. (2017) · Addiction · doi:10.1111/add.13807 · Cited by 51
Self-citationLee, J. D., Friedmann, P. D., Boney, T. Y., Hoskinson, R. A., McDonald, R. D., Gordon, M., Fishman, M. J., Chen, D. T., Bonnie, R. J., Kinlock, T. W., et al. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.01.005 · Cited by 29
Self-citationFriedmann, P. D., Wilson, D., Nunes, E. V., Hoskinson, R. A., Lee, J. D., Gordon, M., Murphy, S. M., Bonnie, R. J., Chen, D. T., Boney, T. Y., et al. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.01.018 · Cited by 26
Self-citationSociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine
Landis, R. K., Levin, J. S., Saloner, B. K., Gordon, A. J., Dick, A. W., Sherry, T. B., LESLIE, D. L., Sorbero, M., & Stein, B. D. (2022) · Substance Abuse · doi:10.1080/08897077.2022.2060424 · Cited by 23
Ryan, D. A., Montoya, I. D., Koutoujian, P. J., Siddiqi, K., Hayes, E., Jeng, P. J., Cadet, T., McCollister, K. E., & Murphy, S. M. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2022.208943 · Cited by 21
Satcher, M. F., Belenko, S. R., Coetzer-Liversage, A., Wilson, K. J., McCart, M. R., Drazdowski, T. K., Fallin‐Bennett, A., Zaller, N. D., Schultheis, A. M., Hogue, A., et al. (2024) · Health & Justice · doi:10.1186/s40352-024-00291-8 · Cited by 25
Vail, W. L., Faro, E. Z., Watnick, D. L., Giftos, J., & Fox, A. D. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108529 · Cited by 22
Martin, R. A., Stein, L. A. R., Rohsenow, D. J., Belenko, S. R., Hurley, L., Clarke, J. G., & Brinkley‐Rubinstein, L. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108364 · Cited by 20
Murphy, S. M., Jeng, P. J., Poole, S. A., Jalali, A., Vocci, F. J., Gordon, M., WOODY, G. E., & Polsky, D. E. (2020) · Addiction Science & Clinical Practice · doi:10.1186/s13722-020-00188-5 · Cited by 19
Self-citationPharmacotherapy for opioid addiction in community corrections
Schwartz, R. P., Mitchell, M. M., O’Grady, K. E., Kelly, S. M., Gryczynski, J., Mitchell, S. G., Gordon, M., & Jaffe, J. H. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1524373 · Cited by 13
Self-citationRiggins, D. P., Cunningham, C. O., Ning, Y. M., & Fox, A. D. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1220443 · Cited by 13
Treating Opioid Use Disorder and Related Infectious Diseases in the Criminal Justice System
Winetsky, D. E., Fox, A. D., Nijhawan, A. E., & Rich, J. D. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.06.012 · Cited by 8
Kopak, A. M. (2015) · International Journal of Prisoner Health · doi:10.1108/ijph-07-2014-0023 · Cited by 8
Pericot‐Valverde, I., Perez, A., Heo, M., Coleman, A., Ortiz, E. G., Merchant, K., Melling, T., & Litwin, A. H. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100918 · Cited by 7
Bhugra, D. K. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1435761 · Cited by 1
Sanger, K. (2021) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/13277964
Pericot‐Valverde, I., Heo, M., Byrne, K. A., Karasz, A., Perez, A., Lopes, S. S., Groome, M., Voss, S., King, A., Barnick, K., et al. (2026) · Contemporary Clinical Trials · doi:10.1016/j.cct.2026.108226
Gagnon, K. W., Baldwin, M., Alnashri, Y., Jaiswal, J., Cropsey, K. L., & Eaton, E. (2026) · Addiction Science & Clinical Practice · doi:10.1186/s13722-026-00700-3
Metadata
- Authors
- Gordon, M. S., Kinlock, T. W., Schwartz, R. P., Couvillion, K. A., Sudec, L. J., O'Grady, K. E., Vocci, F. J., & Shabazz, H.
- Affiliations
- Stevenson University (US)
- Friends Research Institute (US)
- Department of Psychology, University of Maryland, College Park, College Park, Maryland, USA
- Corresponding author
- Gordon, Michael S.
- Venue
- Substance Abuse
- Publisher
- SAGE Publications
- Published
- 2015-04
- Volume
- 36
- Issue
- 2
- Pages
- 217-225
- ISSN
- 0889-7077 (ISSN-L)
- 1547-0164
- PMC
- PMC4185269
- OpenAlex
- W2094916125
- Cited by
- 21
- References
- 42
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 2 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 3
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Substance Abuse (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA021579)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Sociology and Political Science › Criminal Justice and Corrections Analysis
- Keywords
- buprenorphine, opioid use disorder, probationers, parolees, community corrections, community-based treatment, heroin use, recidivism, treatment retention, criminal justice involvement
- MeSH terms
- Analgesics, Opioid, Buprenorphine, Female, Humans, Longitudinal Studies, Male, Middle Aged, Opioid-Related Disorders, Treatment Outcome, Criminals, Opiate Substitution Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
